Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression

Journal of Virology

Volumn 75, Issue 10, 2001, Pages 4907-4911

  Islam, S A ^a   Hay, C M ^a   Hartman, K E ^a   He, S ^a   Shea, A K ^a   Trocha, A K ^a   Dynan, M J ^a   Reshamwala, N ^a   Buchbinder, S P ^a   Basgoz, N O ^a   Kalams, S A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE CLONE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIREMIA;

CHRONIC DISEASE; CLONE CELLS; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0035028005     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.10.4907-4911.2001     Document Type: Article

References (22)

1. Immunological memory and protective immunity: Understanding their relation
2. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
3. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
4. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
5. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection
6. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
7. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes
8. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection
9. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
10. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant
11. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire
12. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
13. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
14. Polymerase chain reaction with single-sided specificity: Analysis of T cell receptor d chain
15. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
16. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
17. Major expansion of CDS+ T cells with a predominant V beta usage during the primary immune response to HIV
18. Evidence for rapid disappearance of initially expanded HIV-specific CDS+ T cell clones during primary HIV infection
19. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
20. Detection of individual mouse splenic T cells producing IFN-V and IL-5 using the enzyme-linked immunospot (ELISPOT) assay
21. HIV-specific cytotoxic T lymphocytes in seropositive individuals
22. Viral immune evasion due to persistence of activated T cells without effector function